Arkema (OTCMKTS:ARKAY) Sees Unusually-High Trading Volume – What’s Next?

Shares of Arkema SA (OTCMKTS:ARKAY) saw an uptick in trading volume on Tuesday . 4,372 shares changed hands during mid-day trading, a decline of 26% from the previous session’s volume of 5,905 shares.The stock last traded at $67.83 and had previously closed at $66.5847.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on ARKAY. Kepler Capital Markets downgraded shares of Arkema from a “strong-buy” rating to a “hold” rating in a report on Friday, February 27th. The Goldman Sachs Group upgraded shares of Arkema from a “hold” rating to a “buy” rating in a research report on Tuesday, February 10th. Finally, Zacks Research cut Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 6th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Reduce”.

Arkema Stock Performance

The stock has a market cap of $5.19 billion, a price-to-earnings ratio of 78.49, a P/E/G ratio of 1.69 and a beta of 0.87. The company has a quick ratio of 1.63, a current ratio of 2.13 and a debt-to-equity ratio of 0.54. The company has a 50 day simple moving average of $66.52 and a 200 day simple moving average of $62.87.

Arkema Company Profile

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.